论文部分内容阅读
Objective:Peripheral T-cell lymphomas (PTCLs) confer dismal prognosis and no consensus has been established on the role of allogeneichematopoietic stem cell transplantation (allo-HSCT) due to its rarity and heterogeneity.The purpose was to review key points of allo-HSCT for PTCLs,including indication,times of transplantation,conditioning regimen,graft versus host disease prophylaxis,and treatment of relapse.Data Sources:A comprehensive search in PubMed and Cochrane up to February 28,2018,with the keywords Peripheral,T,Lymphoma,and Transplantation was done.Study Selection:Relevant articles including HSCT for PTCLs were carefully reviewed.Results:Promising data have been reported from advances in transplant technology and more and more PTCLs patients with poor prognosis could benefit from allo-HSCT.Conclusion:Allo-HSCT is a useful choice for patients with refractory/relapsed PTCLs or high-risk new diagnosed PTCLs.